OCTOBER 2023LIFE SCIENCES REVIEW4IN MY OPINIONPiero Rijli, Corporate Director, Regulatory Activities and Market Access, MENARINI GroupThe value of new antibiotics in the fight against AMR0812COVER STORYCONTENTSFEATURED CompanyBIOSIMILARSERVICES PROVIDERS IN EUROPE - 2023TOP 10Zafer Toksöz, Owner16Arven PharmaceuticalsBy Marc de Garidel, CEO and Interim Chairman, AbivaxLEVERAGING TECHNOLOGICAL ADVANCEMENTS FOR DEVELOPING INNOVATIVE THERAPEUTICS
< Page 3 | Page 5 >